Cargando…

주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)

The Korean Society of Radiology and Medical Guidelines Committee amended the existing 2016 guidelines to publish the “Korean Clinical Practice Guidelines for Adverse Reactions to Iodide Contrast for Injection and Gadolinium Contrast for MRI: The Revised Clinical Consensus and Recommendations (2022 T...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514440/
https://www.ncbi.nlm.nih.gov/pubmed/36237922
http://dx.doi.org/10.3348/jksr.2022.0024
_version_ 1784798275689250816
collection PubMed
description The Korean Society of Radiology and Medical Guidelines Committee amended the existing 2016 guidelines to publish the “Korean Clinical Practice Guidelines for Adverse Reactions to Iodide Contrast for Injection and Gadolinium Contrast for MRI: The Revised Clinical Consensus and Recommendations (2022 Third Edition).” Expert members recommended and approved by the Korean Society of Radiology, the Korean Academy of Asthma, Allergy and Clinical Immunology, and the Korean Nephrology Society participated together. According to the expert consensus or systematic literature review, the description of the autoinjector and connection line for the infection control while using contrast medium, the acute adverse reaction, and renal toxicity to iodized contrast medium were modified and added. We would like to introduce the revised contents.
format Online
Article
Text
id pubmed-9514440
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Society of Radiology
record_format MEDLINE/PubMed
spelling pubmed-95144402022-10-12 주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판) Taehan Yongsang Uihakhoe Chi The Latest Guidelines of the Korean Society of Radiology The Korean Society of Radiology and Medical Guidelines Committee amended the existing 2016 guidelines to publish the “Korean Clinical Practice Guidelines for Adverse Reactions to Iodide Contrast for Injection and Gadolinium Contrast for MRI: The Revised Clinical Consensus and Recommendations (2022 Third Edition).” Expert members recommended and approved by the Korean Society of Radiology, the Korean Academy of Asthma, Allergy and Clinical Immunology, and the Korean Nephrology Society participated together. According to the expert consensus or systematic literature review, the description of the autoinjector and connection line for the infection control while using contrast medium, the acute adverse reaction, and renal toxicity to iodized contrast medium were modified and added. We would like to introduce the revised contents. The Korean Society of Radiology 2022-03 2022-03-28 /pmc/articles/PMC9514440/ /pubmed/36237922 http://dx.doi.org/10.3348/jksr.2022.0024 Text en Copyrights © 2022 The Korean Society of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle The Latest Guidelines of the Korean Society of Radiology
주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)
title 주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)
title_full 주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)
title_fullStr 주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)
title_full_unstemmed 주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)
title_short 주사용 요오드화 조영제 및 MRI용 가돌리늄 조영제 유해반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)
title_sort 주사용 요오드화 조영제 및 mri용 가돌리늄 조영제 유해반응에 대한 한국 임상진료지침: 개정된 임상적 합의 및 권고안(2022년 제3판)
topic The Latest Guidelines of the Korean Society of Radiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514440/
https://www.ncbi.nlm.nih.gov/pubmed/36237922
http://dx.doi.org/10.3348/jksr.2022.0024
work_keys_str_mv AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan
AT jusayongyoodeuhwajoyeongjemichmriyonggadollinyumjoyeongjeyuhaebaneungedaehanhangugimsangjinlyojichimgaejeongdoenimsangjeoghabuimichgwongoan2022nyeonje3pan